Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial

Nutrition

Volumn 30, Issue 7-8, 2014, Pages 814-821

  Kani, Ali Hashemi ^a,b   Alavian, Seyed Moayed ^c   Esmaillzadeh, Ahmad ^a,b   Adibi, Peyman ^b   Azadbakht, Leila ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coagulation; Lipid abnormalities; Low calorie diet; Low carbohydrate diet; Non alcoholic fatty liver; Soy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; INSULIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; TRIACYLGLYCEROL; LIPID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LOW CALORY DIET; LOW CARBOHYDRATE DIET; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; BLOOD; BODY WEIGHT; CALORIC INTAKE; CALORIC RESTRICTION; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; LIVER; METABOLISM; MIDDLE AGED; OBESITY; PLANT SEED;

ADULT; ALANINE TRANSAMINASE; BODY WEIGHT; CALORIC RESTRICTION; DIET, CARBOHYDRATE-RESTRICTED; DIET, REDUCING; ENERGY INTAKE; FEMALE; FIBRINOGEN; HUMANS; LIPIDS; LIVER; MALE; MALONDIALDEHYDE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; SEEDS; SOYBEANS;

EID: 84903382544     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.11.008     Document Type: Article

References (40)

1. Fan J.G., Saibara T., Chitturi S., Kim B.I., Sung J.J., Chutaputti A. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?. J Gastroenterol Hepatol 2007, 22:794-800.
2. Kawada T. Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease. J Gastroenterol 2013, 48:671-672.
3. Kawano Y., Cohen D.E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 2013, 48:434-441.
4. Bruckert E., Ankri A., Jung M., Turpin G., De Gennes J.L. Mild liver abnormalities associated with elevated plasma factor VII and protein C in hypertriglyceridaemic patients. Eur J Med 1993, 2:461-465.
5. Carvalhana S., Machado M.V., Cortez-Pinto H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2012, 15:468-473.
6. Scaglioni F., Marino M., Ciccia S., Procaccini A., Busacchi M., Loria P., et al. Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD). Clin Res Hepatol Gastroenterol 2013, 37:353-358.
7. Liu T., Yang L.L., Zhang L., Song H.Y., Li D.F., Ji G. Zhong Xi Yi Jie He Xue Bao 2012, 10:1120-1126.
8. Morita M., Ishida N., Uchiyama K., Yamaguchi K., Itoh Y., Shichiri M., et al. Fatty liver induced by free radicals and lipid peroxidation. Free Radic Res 2012, 46:758-765.
9. van der Meer R.W., Hammer S., Lamb H.J., Frölich M., Diamant M., Rijzewijk L.J., et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 2008, 93:2702-2708.
10. Nazarenko L.I., Petrova Iu.N., Raǐkhel'son K.L., Baranovskiǐ AIu Nutrition mistakes in patients with nonalcoholic fatty liver disease and the ways of correction. Eksp Klin Gastroenterol 2012, 2:19-24.
11. Agius L. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload. Biochem Pharmacol 2013, 85:306-312.
12. Caporaso N., Morisco F., Camera S., Graziani G., Donnarumma L., Ritieni A. Dietary approach in the prevention and treatment of NAFLD. Front Biosci 2012, 17:2259-2268.
13. Yang H.Y., Tzeng Y.H., Chai C.Y., Hsieh A.T., Chen J.R., Chang L.S., et al. Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. Nutrition 2011, 27:943-948.
14. Leng L., Jiang Z.Q., Ji G.Y. Effects of soybean isoflavone on liver lipid metabolism in nonalcoholic fatty liver rats. Zhonghua Yu Fang Yi Xue Za Zhi 2011, 45:335-339.
15. Badger T.M., Ronis M.J., Wolff G., Stanley S., Ferguson M., Shankar K., et al. Soy protein isolate reduces hepatosteatosis in yellow Avy/a mice without altering coat color phenotype. Exp Biol Med (Maywood) 2008, 233:1242-1254.
16. Mohamed Salih S., Nallasamy P., Muniyandi P., Periyasami V., Carani Venkatraman A. Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. J Diabetes 2009, 1:278-287.
17. Oliveira L.P., de Jesús R.P., Freire T.O., Oliveira C.P., Castro Lyra A., Lyra L.G. Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease. Nutr Hosp 2012, 27:991-998.
18. Torres y Torres N., Palacios-González B., Noriega-López L., Tovar-Palacio A.R. Glycemic, insulinemic index, glycemic load of soy beverage with low and high content of carbohydrates. Rev Invest Clin 2006, 58:487-497.
19. Azadbakht L., Surkan P.J., Esmaillzadeh A., Willett W.C. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr 2011, 141:1083-1088.
20. Institute of Medicine, Food and Nutrition Board Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids 2002, National Academies Press, Washington, DC.
21. Miraghajani M.S., Najafabadi M.M., Surkan P.J., Esmaillzadeh A., Mirlohi M., Azadbakht L. Soy milk consumption and blood pressure among type 2 diabetic patients with nephropathy. J Ren Nutr 2013, 23:277-282.
22. Badger T.M., Ronis M.J.J., Wolff G., Stanley S., Ferguson M., Shankar K., et al. Reduces hepatosteatosis in yellow Avy/a mice without altering coat color phenotype. Exp Biol Med 2008, 233:1242-1254.
23. Azadbakht L., Atabak S., Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 2008, 31:648-654.
24. Azadbakht L., Kimiagar M., Mehrabi Y., Esmaillzadeh A., Padyab M., Hu F.B., et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 2007, 85:735-741.
25. Onuegbu A.J., Olisekodiaka J.M., Onibon M.O., Adesiyan A.A., Igbeneghu C.A. Consumption of soymilk lowers atherogenic lipid fraction in healthy individuals. J Med Food 2011, 14:257-260.
26. Kriengsinyos W., Sumriddetchkajorn K., Yamborisut U. Reduction of LDL-cholesterol in mildly hypercholesterolemic Thais with plant stanol ester-fortified soy milk. J Med Assoc Thai 2011, 94:1327-1336.
27. Ma L., Grann K., Li M., Jiang Z. A pilot study to evaluate the effect of soy isolate protein on the serum lipid profile and other potential cardiovascular risk markers in moderately hypercholesterolemic Chinese adults. Ecol Food Nutr 2011, 50:473-485.
28. Azadbakht L., Kimiagar M., Mehrabi Y., Esmaillzadeh A., Hu F.B., Willett W.C. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. Br J Nutr 2007, 98:807-813.
29. Azadbakht L., Esmaillzadeh A. A cross-over trial on soy intake and serum leptin levels in women with metabolic syndrome. J Res Med Sci 2010, 15:317-323.
30. Zhang Y.B., Chen W.H., Guo J.J., Fu Z.H., Yi C., Zhang M., et al. Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-a meta-analysis. Nutrition 2013, 29:8-14.
31. Li Z., Hong K., Saltsman P., DeShields S., Bellman M., Thames G., et al. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 2005, 59:411-418.
32. Mohammadshahi M., Haidari F., Saei A.A., Rashidi B., Mahboob S., Rashidi M.R. Soy protein, genistein, and daidzein improve serum paraoxonase activity and lipid profiles in rheumatoid arthritis in rats. J Med Food 2013, 16:147-154.
33. Tang X., Wu Q., Le G., Shi Y. Effects of heat treatment on structural modification and invivo antioxidant capacity of soy protein. Nutrition 2012, 28:1180-1185.
34. Obarzanek E., Sacks F.M., Vollmer W.M., Bray G.A., Miller E.R., Lin P.H., et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001, 74:80-89. DASH Research Group.
35. Boman K., Hellsten G., Bruce A., Hallmans G., Nilsson T.K. Endurance physical activity, diet and fibrinolysis. Atherosclerosis 1994, 106:65-74.
36. Fehily A.M., Burr M.L., Butland B.K., Eastham R.D. A randomized controlled trial to investigate the effect of a high fiber diet on blood pressure and plasma fibrinogen. J Epidemiol Community Health 1986, 40:334-337.
37. Djoussé L., Ellison R.C., Zhang Y., Arnett D.K., Sholinsky P., Borecki I. Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 1998, 68:568-575.
38. Juhan-Vague I., Thompson S.G., Jespersen J. Involvement of hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb 1993, 13:1865-1873.
39. Huang Y., Cao S., Nagamani M., Anderson K.E., Grady J.J., Lu L.J. Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab 2005, 90:3956-3962.
40. Kano M., Takayanagi T., Harada K., Sawada S., Ishikawa F. Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr 2006, 136:2291-2296.